Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
2020-12-16
SCID: 54.1/yjt7gzyd
Publication Details
Publication Date
2020-12-16
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF